Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

High-Density Genetic Mapping Identifies New Susceptibility Variants in Sarcoidosis Phenotypes and Shows Genomic-driven Phenotypic Differences

NV. Rivera, M. Ronninger, K. Shchetynsky, A. Franke, MM. Nöthen, J. Müller-Quernheim, S. Schreiber, I. Adrianto, B. Karakaya, CH. van Moorsel, Z. Navratilova, V. Kolek, BA. Rybicki, MC. Iannuzzi, M. Petrek, JC. Grutters, C. Montgomery, A....

. 2016 ; 193 (9) : 1008-22.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17024204
E-zdroje Online Plný text

NLK Free Medical Journals od 1997-07-01 do Před 1 rokem
Freely Accessible Science Journals od 1997 do Před 1 rokem
ProQuest Central od 2003-02-01 do 2019-09-15
Open Access Digital Library od 1998-01-01
Nursing & Allied Health Database (ProQuest) od 2003-02-01 do 2019-09-15
Health & Medicine (ProQuest) od 2003-02-01 do 2019-09-15
Public Health Database (ProQuest) od 2003-02-01 do 2019-09-15

RATIONALE: Sarcoidosis is a multisystem disease of unknown cause. Löfgren's syndrome (LS) is a characteristic subgroup of sarcoidosis that is associated with a good prognosis in sarcoidosis. However, little is known about its genetic architecture or its broader phenotype, non-LS sarcoidosis. OBJECTIVES: To address the genetic architecture of sarcoidosis phenotypes, LS and non-LS. METHODS: An association study in a white Swedish cohort of 384 LS, 664 non-LS, and 2,086 control subjects, totaling 3,134 subjects using a fine-mapping genotyping platform was conducted. Replication was performed in four independent cohorts, three of white European descent (Germany, n = 4,975; the Netherlands, n = 613; and Czech Republic, n = 521), and one of black African descent (United States, n = 1,657), totaling 7,766 subjects. MEASUREMENTS AND MAIN RESULTS: A total of 727 LS-associated variants expanding throughout the extended major histocompatibility complex (MHC) region and 68 non-LS-associated variants located in the MHC class II region were identified and confirmed. A shared overlap between LS and non-LS defined by 17 variants located in the MHC class II region was found. Outside the MHC region, two LS-associated loci, in ADCY3 and between CSMD1 and MCPH1, were observed and replicated. CONCLUSIONS: Comprehensive and integrative analyses of genetics, transcription, and pathway modeling on LS and non-LS indicates that these sarcoidosis phenotypes have different genetic susceptibility, genomic distributions, and cellular activities, suggesting distinct molecular mechanisms in pathways related to immune response with a common region.

Arthritis and Clinical Immunology Research Program Oklahoma Medical Research Foundation Oklahoma City Oklahoma

Center for Molecular Medicine and 3 Rheumatology Unit Department of Medicine Karolinska Institutet Stockholm Sweden

Center of Interstitial Lung Diseases St Antonius Hospital Nieuwegein the Netherlands

Center of Interstitial Lung Diseases St Antonius Hospital Nieuwegein the Netherlands 12 Division of Heart and Lungs University Medical Center Utrecht Utrecht the Netherlands

Department of Pathological Physiology and

Department of Pneumology University of Freiburg Freiburg Germany

Department of Public Health Sciences Henry Ford Health Systems Detroit Michigan

Department of Respiratory Medicine Faculty of Medicine and Dentistry Palacky University Olomouc Olomouc Czech Republic

Institute of Clinical Molecular Biology University Hospital Schleswig Holstein Campus Kiel and Kiel University Kiel Germany

Institute of Clinical Molecular Biology University Hospital Schleswig Holstein Campus Kiel and Kiel University Kiel Germany 8 Popgen Biobank and 9 Clinic of Internal Medicine 1 University Hospital Schleswig Holstein Kiel Germany

Institute of Human Genetics and 6 Department of Genomics Life and Brain Center University of Bonn Bonn Germany

Respiratory Unit Department of Medicine Karolinska Institutet Karolinska University Hospital Stockholm Sweden

Respiratory Unit Department of Medicine Karolinska Institutet Karolinska University Hospital Stockholm Sweden 2 Center for Molecular Medicine and

State University of New York Upstate Medical University Syracuse Syracuse New York

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17024204
003      
CZ-PrNML
005      
20200923165515.0
007      
ta
008      
170720s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1164/rccm.201507-1372OC $2 doi
035    __
$a (PubMed)26651848
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Rivera, Natalia V $u 1 Respiratory Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. 2 Center for Molecular Medicine, and.
245    10
$a High-Density Genetic Mapping Identifies New Susceptibility Variants in Sarcoidosis Phenotypes and Shows Genomic-driven Phenotypic Differences / $c NV. Rivera, M. Ronninger, K. Shchetynsky, A. Franke, MM. Nöthen, J. Müller-Quernheim, S. Schreiber, I. Adrianto, B. Karakaya, CH. van Moorsel, Z. Navratilova, V. Kolek, BA. Rybicki, MC. Iannuzzi, M. Petrek, JC. Grutters, C. Montgomery, A. Fischer, A. Eklund, L. Padyukov, J. Grunewald,
520    9_
$a RATIONALE: Sarcoidosis is a multisystem disease of unknown cause. Löfgren's syndrome (LS) is a characteristic subgroup of sarcoidosis that is associated with a good prognosis in sarcoidosis. However, little is known about its genetic architecture or its broader phenotype, non-LS sarcoidosis. OBJECTIVES: To address the genetic architecture of sarcoidosis phenotypes, LS and non-LS. METHODS: An association study in a white Swedish cohort of 384 LS, 664 non-LS, and 2,086 control subjects, totaling 3,134 subjects using a fine-mapping genotyping platform was conducted. Replication was performed in four independent cohorts, three of white European descent (Germany, n = 4,975; the Netherlands, n = 613; and Czech Republic, n = 521), and one of black African descent (United States, n = 1,657), totaling 7,766 subjects. MEASUREMENTS AND MAIN RESULTS: A total of 727 LS-associated variants expanding throughout the extended major histocompatibility complex (MHC) region and 68 non-LS-associated variants located in the MHC class II region were identified and confirmed. A shared overlap between LS and non-LS defined by 17 variants located in the MHC class II region was found. Outside the MHC region, two LS-associated loci, in ADCY3 and between CSMD1 and MCPH1, were observed and replicated. CONCLUSIONS: Comprehensive and integrative analyses of genetics, transcription, and pathway modeling on LS and non-LS indicates that these sarcoidosis phenotypes have different genetic susceptibility, genomic distributions, and cellular activities, suggesting distinct molecular mechanisms in pathways related to immune response with a common region.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetická predispozice k nemoci $x genetika $7 D020022
650    _2
$a genomika $x metody $7 D023281
650    12
$a genotyp $7 D005838
650    _2
$a Německo $7 D005858
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a Nizozemsko $7 D009426
650    12
$a fenotyp $7 D010641
650    _2
$a plicní sarkoidóza $x genetika $7 D017565
650    _2
$a Švédsko $7 D013548
650    _2
$a Spojené státy americké $7 D014481
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ronninger, Marcus $u 1 Respiratory Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. 2 Center for Molecular Medicine, and.
700    1_
$a Shchetynsky, Klementy $u 2 Center for Molecular Medicine, and. 3 Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Franke, Andre $u 4 Institute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Campus Kiel and Kiel University, Kiel, Germany.
700    1_
$a Nöthen, Markus M $u 5 Institute of Human Genetics, and. 6 Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
700    1_
$a Müller-Quernheim, Joachim $u 7 Department of Pneumology, University of Freiburg, Freiburg, Germany.
700    1_
$a Schreiber, Stefan $u 4 Institute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Campus Kiel and Kiel University, Kiel, Germany. 8 Popgen Biobank and. 9 Clinic of Internal Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany.
700    1_
$a Adrianto, Indra $u 10 Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma. $7 gn_A_00001903
700    1_
$a Karakaya, Bekir $u 11 Center of Interstitial Lung Diseases, St. Antonius Hospital, Nieuwegein, the Netherlands.
700    1_
$a van Moorsel, Coline H M $u 11 Center of Interstitial Lung Diseases, St. Antonius Hospital, Nieuwegein, the Netherlands. 12 Division of Heart & Lungs, University Medical Center Utrecht, Utrecht, the Netherlands.
700    1_
$a Navratilova, Zdenka $u 13 Department of Pathological Physiology and.
700    1_
$a Kolek, Vitezslav $u 14 Department of Respiratory Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
700    1_
$a Rybicki, Benjamin A $u 15 Department of Public Health Sciences, Henry Ford Health Systems, Detroit, Michigan; and.
700    1_
$a Iannuzzi, Michael C $u 16 State University of New York Upstate Medical University Syracuse, Syracuse, New York.
700    1_
$a Petrek, Martin $u 13 Department of Pathological Physiology and.
700    1_
$a Grutters, Jan C $u 11 Center of Interstitial Lung Diseases, St. Antonius Hospital, Nieuwegein, the Netherlands. 12 Division of Heart & Lungs, University Medical Center Utrecht, Utrecht, the Netherlands.
700    1_
$a Montgomery, Courtney $u 10 Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma.
700    1_
$a Fischer, Annegret $u 4 Institute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Campus Kiel and Kiel University, Kiel, Germany.
700    1_
$a Eklund, Anders $u 1 Respiratory Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
700    1_
$a Padyukov, Leonid $u 2 Center for Molecular Medicine, and. 3 Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Grunewald, Johan $u 2 Center for Molecular Medicine, and. 3 Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
773    0_
$w MED00000297 $t American journal of respiratory and critical care medicine $x 1535-4970 $g Roč. 193, č. 9 (2016), s. 1008-22
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26651848 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20200923165512 $b ABA008
999    __
$a ok $b bmc $g 1239885 $s 985117
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 193 $c 9 $d 1008-22 $i 1535-4970 $m American journal of respiratory and critical care medicine $n Am J Respir Crit Care Med $x MED00000297
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...